↓ Skip to main content

Cochrane Database of Systematic Reviews

Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD)

Overview of attention for article published in Cochrane database of systematic reviews, December 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
17 X users
facebook
2 Facebook pages

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
177 Mendeley
Title
Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD)
Published in
Cochrane database of systematic reviews, December 2018
DOI 10.1002/14651858.cd011594.pub2
Pubmed ID
Authors

Han Ni, Soe Moe, Zay Soe, Kay Thi Myint, K Neelakantan Viswanathan

X Demographics

X Demographics

The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 177 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 177 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 27 15%
Student > Bachelor 22 12%
Researcher 14 8%
Student > Ph. D. Student 14 8%
Student > Postgraduate 7 4%
Other 28 16%
Unknown 65 37%
Readers by discipline Count As %
Medicine and Dentistry 50 28%
Nursing and Health Professions 18 10%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Psychology 6 3%
Economics, Econometrics and Finance 4 2%
Other 19 11%
Unknown 73 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 June 2021.
All research outputs
#2,765,415
of 25,806,763 outputs
Outputs from Cochrane database of systematic reviews
#5,391
of 13,140 outputs
Outputs of similar age
#59,824
of 448,060 outputs
Outputs of similar age from Cochrane database of systematic reviews
#128
of 219 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,060 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 219 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.